Osmind
Osmind, based in San Francisco, CA, offers a specialized electronic health record (EHR) platform for neuropsychiatric clinics, supporting advanced treatments like ketamine and psychedelic medicine, and is recognized for its contributions to mental health research.
About Osmind
Osmind is a healthcare IT company based in San Francisco, CA, focused on advancing mental health research and treatment. Founded in 2020 as part of the Y-Combinator S20 batch, the company has grown to a team of 55 employees. Osmind provides a specialized electronic health record (EHR) platform tailored for neuropsychiatric clinics. The platform supports treatments such as transcranial magnetic stimulation, ketamine, SPRAVATO®, psychedelic medicine, and electroconvulsive therapy. Recognized for its innovation, Osmind was named to the 2021 CB Insights Digital Health 150 and one of the 21 most promising health tech startups of 2022.
Services Offered by Osmind
Osmind offers a comprehensive EHR platform designed specifically for interventional treatment workflows in neuropsychiatric clinics. Key features include journaling tools, assistance with health plan reimbursement, seamless charting, outcomes tracking, and patient engagement improvement. The platform also integrates Zoom for psychiatric telehealth services, providing a convenient telehealth option for providers and patients. Osmind supports a range of treatments including transcranial magnetic stimulation, ketamine, SPRAVATO®, psychedelic medicine, and electroconvulsive therapy.
Research and Publications
Osmind conducts multiple ongoing research studies leveraging proprietary real-world data and machine learning. Collaborations with institutions like Stanford University School of Medicine have led to publications in esteemed journals such as the Journal of Affective Disorders. The company's research efforts aim to advance new evidence-based medicine for people with moderate to severe mental health conditions. Osmind’s contributions to mental health research and treatment have been highlighted in industry news articles by outlets like Fierce Healthcare and Stanford Biodesign.
Investors and Funding
Osmind is backed by leading investors including DFJ Growth, General Catalyst, Future Ventures, Tiger Global, and Y Combinator. These investors recognize Osmind’s potential to revolutionize mental health treatment and research through its innovative EHR platform and data-driven approach. The company's growth and continued development of its technology are supported by substantial investment from these top-tier venture capital firms.
Osmind Blog and Resources
Osmind maintains a comprehensive blog featuring articles on mental health treatment and research. The blog provides insights into the latest developments in neuropsychiatric treatments and showcases the company's ongoing research efforts. Additionally, Osmind offers a demo of its EHR platform on its website, allowing potential clients to experience its capabilities firsthand. The company integrates with Chili Piper to facilitate easy scheduling of demo sessions directly from the website.